Premium
P4‐389: An oral antagonist of the receptor for advanced glycation end products (RAGE) is safe and well‐tolerated in the treatment of Alzheimer's disease: Results from a phase II study
Author(s) -
Sabbagh Marwan N.,
Bell Joanne,
Agro Albert,
Aisen Paul,
Galasko Douglas
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.2459
Subject(s) - placebo , medicine , tolerability , rage (emotion) , adverse effect , clinical endpoint , antagonist , randomized controlled trial , pharmacology , gastroenterology , receptor , pathology , psychology , alternative medicine , neuroscience